Jyong Biotech Ltd. (MENS)
Nasdaq: MENS · Pharmaceutical Preparations · New Taipei City, TW · filing with the SEC since 2023
Who runs Jyong Biotech Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Kuo Fu-Feng
CEO. First filing Apr 2026, latest Apr 8, 2026, 0 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
6 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Zhang Wei (Vivi) | CFO | Apr 2026 | Apr 14, 2026 | none |
| Kuo Fu-Feng | CEO | Apr 2026 | Apr 8, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chi Pang-Chieh | director | Apr 2026 | Apr 1, 2026 | none |
| Fan Hung-Shu | director | Apr 2026 | Apr 1, 2026 | none |
| Hsu Feng-Lin | director | Apr 2026 | Apr 1, 2026 | none |
| Hsu Ming Tsan | director | Apr 2026 | Apr 1, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.